136 related articles for article (PubMed ID: 27637429)
1. Preparation, characterization, and in vitro evaluation of bleomycin-containing nanoliposomes.
Chiani M; Shokrgozar MA; Azadmanesh K; Norouzian D; Mehrabi MR; Najmafshar A; Akbarzadeh A
Chem Biol Drug Des; 2017 Apr; 89(4):492-497. PubMed ID: 27637429
[TBL] [Abstract][Full Text] [Related]
2. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells.
Saini J; Bansal V; Chandra A; Madan J; Jain UK; Chandra R; Jain SM
Colloids Surf B Biointerfaces; 2014 Jun; 118():101-10. PubMed ID: 24732397
[TBL] [Abstract][Full Text] [Related]
4. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin: revival of an old drug.
Mir LM; Tounekti O; Orlowski S
Gen Pharmacol; 1996 Jul; 27(5):745-8. PubMed ID: 8842674
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D.
Shahbazian S; Akbarzadeh A; Torabi S; Omidi M
Biotechnol Lett; 2015 Jul; 37(7):1355-9. PubMed ID: 25792512
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system.
Ding W; Li Y; Hou X; Li G
Drug Deliv; 2016; 23(1):88-94. PubMed ID: 24845479
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma.
Rastgoo M; Hosseinzadeh H; Alavizadeh H; Abbasi A; Ayati Z; Jaafari MR
Planta Med; 2013 Apr; 79(6):447-51. PubMed ID: 23539350
[TBL] [Abstract][Full Text] [Related]
9. A novel micro-emulsion and micelle assembling method to prepare DEC205 monoclonal antibody coupled cationic nanoliposomes for simulating exosomes to target dendritic cells.
Li K; Chang S; Wang Z; Zhao X; Chen D
Int J Pharm; 2015 Aug; 491(1-2):105-12. PubMed ID: 26073939
[TBL] [Abstract][Full Text] [Related]
10. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro].
Zhang HQ; He NG; Xue SB
Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
He NG; Zhang HQ; Wang RH; Yang XL; Xue SB
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.
Eloy JO; Petrilli R; Brueggemeier RW; Marchetti JM; Lee RJ
Anticancer Agents Med Chem; 2017; 17(1):48-56. PubMed ID: 27225450
[TBL] [Abstract][Full Text] [Related]
13. Influence of p53 expression on sensitivity of cancer cells to bleomycin.
Lee YS; Yoon S; Park MS; Kim JH; Lee JH; Song CW
J Biochem Mol Toxicol; 2010; 24(4):260-9. PubMed ID: 20135637
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors.
Haeri A; Alinaghian B; Daeihamed M; Dadashzadeh S
Iran J Pharm Res; 2014; 13(Suppl):3-14. PubMed ID: 24711824
[TBL] [Abstract][Full Text] [Related]
15. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
17. [Derivative of bleomycin generates less of ROS? Less of fibrosis? Alternative in the development of an efficacy anticancer therapy but less toxic].
Brahim S; Bettaieb A; Kenani A
Bull Cancer; 2010 May; 97(5):527-34. PubMed ID: 20100681
[TBL] [Abstract][Full Text] [Related]
18. Use of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosis.
Haeri A; Sadeghian S; Rabbani S; Anvari MS; Boroumand MA; Dadashzadeh S
Int J Pharm; 2011 Jul; 414(1-2):16-27. PubMed ID: 21554939
[TBL] [Abstract][Full Text] [Related]
19. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B
J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412
[TBL] [Abstract][Full Text] [Related]
20. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
